Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma injections can effectively treat male pattern hair loss, improving hair density and quality with high patient satisfaction.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

5% minoxidil foam is effective and safe for hair regrowth in women with hair loss.

Finasteride increased hair count and regrowth in men with hair loss but also caused more sexual side effects than placebo.

Latanoprost and minoxidil effectively control hair loss and increase hair count.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Melatonin implants did not effectively prevent hair loss in dogs.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Platelet-rich plasma treatment significantly improved hair density and regrowth in both men and women suffering from pattern hair loss, with even better results when combined with certain medications.

PRP combined with minoxidil is the most effective and safe treatment for male pattern baldness.

Platelet-rich plasma injections significantly improved hair regrowth and thickness in patients with hair loss.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

French maritime pine bark extract significantly increased hair density in menopausal women.

PRP is more effective than minoxidil and placebo for treating hair loss.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

Adding cetirizine to minoxidil improves hair growth and thickness in women with androgenetic alopecia.

Dutasteride 0.5mg was found to be more effective than finasteride 1mg in treating male pattern hair loss, with similar side effects.